Cellebrite DI Equity Performance
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
The firm shows a Beta (market volatility) of -0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cellebrite are expected to decrease at a much lower rate. During the bear market, Cellebrite is likely to outperform the market. At this point, Cellebrite DI Equity has a negative expected return of -0.72%. Please make sure to confirm Cellebrite's treynor ratio, as well as the relationship between the expected short fall and day median price , to decide if Cellebrite DI Equity performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cellebrite DI Equity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 87.6 M | |
| Free Cash Flow | 94.1 M |
Cellebrite |
Cellebrite Relative Risk vs. Return Landscape
If you would invest 571.00 in Cellebrite DI Equity on August 29, 2024 and sell it today you would lose (56.00) from holding Cellebrite DI Equity or give up 9.81% of portfolio value over 90 days. Cellebrite DI Equity is currently producing negative expected returns and takes up 3.6852% volatility of returns over 90 trading days. Put another way, 32% of traded stocks are less volatile than Cellebrite, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cellebrite Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellebrite's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cellebrite DI Equity, and traders can use it to determine the average amount a Cellebrite's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1965
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLBTW |
Estimated Market Risk
| 3.69 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.72 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cellebrite is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellebrite by adding Cellebrite to a well-diversified portfolio.
Cellebrite Fundamentals Growth
Cellebrite Stock prices reflect investors' perceptions of the future prospects and financial health of Cellebrite, and Cellebrite fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cellebrite Stock performance.
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| EBITDA | 43.29 M | |||
| Total Debt | 14.13 M | |||
| Book Value Per Share | (0.19) X | |||
| Cash Flow From Operations | 102.06 M | |||
| Earnings Per Share | 0.06 X | |||
| Total Asset | 540.4 M | |||
| Retained Earnings | 118.14 M | |||
About Cellebrite Performance
Evaluating Cellebrite's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Cellebrite has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cellebrite has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Cellebrite DI Equity performance evaluation
Checking the ongoing alerts about Cellebrite for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cellebrite DI Equity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cellebrite DI Equity is not yet fully synchronised with the market data | |
| Cellebrite DI Equity generated a negative expected return over the last 90 days | |
| Cellebrite DI Equity has high historical volatility and very poor performance | |
| Cellebrite DI Equity has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 325.11 M. Net Loss for the year was (81.1 M) with profit before overhead, payroll, taxes, and interest of 219.91 M. |
- Analyzing Cellebrite's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cellebrite's stock is overvalued or undervalued compared to its peers.
- Examining Cellebrite's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cellebrite's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cellebrite's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cellebrite's stock. These opinions can provide insight into Cellebrite's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |